Core Specialty considering joining the ranks of specialty P&C IPOs
If Core Specialty decides later this year to go forward with a public listing – which could value the firm at more than $2bn – it will be another test of investor sentiment towards the group of start-ups and recapitalised companies that emerged in recent years to target hard market conditions.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below